Holen Sie sich die Stockscreener-App
20.24
0.11%
0.0492
Schlusskurs vom Vortag:
$20.19
Offen:
$20.3
24-Stunden-Volumen:
849.39K
Relative Volume:
0.28
Marktkapitalisierung:
$5.17B
Einnahmen:
$810.81M
Nettoeinkommen (Verlust:
$156.02M
KGV:
32.03
EPS:
0.6319
Netto-Cashflow:
$373.47M
1W Leistung:
-3.34%
1M Leistung:
+2.29%
6M Leistung:
+0.21%
1J Leistung:
+9.08%
1-Tages-Spanne:
$20.20
$20.54
1-Wochen-Bereich:
$19.75
$21.14
52-Wochen-Spanne:
$17.16
$22.77
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBRA
Sabra Healthcare Reit Inc
|
20.25 | 5.16B | 810.81M | 156.02M | 373.47M | 0.6319 |
WELL
Welltower Inc
|
234.56 | 165.93B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
90.14 | 45.66B | 6.13B | 272.21M | 1.38B | 0.5521 |
DOC
Healthpeak Properties Inc
|
20.77 | 14.25B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
46.20 | 13.90B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
53.65 | 10.14B | 2.37B | 101.67M | 169.19M | 0.5775 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
How Investors May Respond To Sabra Health Care REIT (SBRA) Profit Reversal And Steady Dividend - simplywall.st
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript - AOL.com
Quantinno Capital Management LP Grows Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Bank of America Corp DE - MarketBeat
Sabra Health Care REIT, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SBRA) 2026-08-07 - Seeking Alpha
California State Teachers Retirement System Grows Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Raymond James upgrades Sabra Healthcare stock on tenant transitions By Investing.com - Investing.com Australia
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation - Yahoo Finance
Raymond James upgrades Sabra Healthcare stock on tenant transitions - Investing.com
Sabra Health Care REIT, Inc. (SBRA) Stock Forecasts - Yahoo Finance
Sabra Healthcare REIT Reports Q2 2026 Results, Growth Investments - The Globe and Mail
Sabra Healthcare REIT Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Sabra Health Care REIT misses Q2 2026 EPS, beats revenue - Investing.com
Sabra Health Care REIT Q2 Revenue Beats Estimates, AFFO Rises to $0.40 - scanx.trade
Loan write-off drives quarterly loss at Sabra Health Care REIT (NASDAQ: SBRA) - Stock Titan
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? By Investing.com - Investing.com South Africa
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? - Investing.com
Janus Henderson Group PLC Reduces Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance - Business Wire
Sei Investments Co. Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Has $11.29 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month HighWhat's Next? - MarketBeat
Sabra Healthcare REIT (SBRA) to Announce Quarterly Earnings on Monday - MarketBeat
BROOKFIELD Corp ON Invests $9.71 Million in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Entropy Technologies LP Purchases 93,021 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
126,500 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Mizuho Markets Americas LLC - MarketBeat
Systematic Financial Management LP Sells 57,628 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Militia Capital Management LLC Buys Shares of 46,000 Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Health Care REIT scales tested technologies across portfolio - McKnight's Senior Living
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report - The Norfolk Daily News
Lasalle Investment Management Securities LLC Has $73.55 Million Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Barclays Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA) - The Globe and Mail
Sabra Healthcare REIT Price Target Raised to $23.00/Share From $22.00 by Baird - Moomoo
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $24.00 - MarketBeat
Citizens raises Sabra Healthcare stock price target on guidance boost - Investing.com India
Citizens Jmp Forecasts Strong Price Appreciation for Sabra Healthcare REIT (NASDAQ:SBRA) Stock - MarketBeat
Sabra Health Care REIT hits 52-week high on str... - Pluang
Strength Seen in Sabra (SBRA): Can Its 10.2% Jump Turn into More Strength? - Yahoo Finance
Citizens raises Sabra Healthcare stock price target on guidance boost By Investing.com - Investing.com Nigeria
SBRA: Sabra's Strategic Transition Aims to Boost Portfolio Value - GuruFocus
Analysts raise Sabra Health Care REIT targets to $24, $23 - scanx.trade
Why Sabra Health Care REIT Stock Soared Today - The Motley Fool
Sabra Health Care REIT to re-tenant 26 SNFs leased to Avamere, increases full-year guidance - McKnight's Senior Living
Sabra Health Care REIT raises 2026 guidance on portfolio moves By Investing.com - Investing.com South Africa
Why Sabra Health Care REIT Stock Soared Today - The Motley Fool
How Investors Are Reacting To Sabra Health Care REIT (SBRA) Re-Tenanting Avamere Portfolio To Boost Cash NOI - simplywall.st
Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 52-Week HighShould You Buy? - MarketBeat
Sabra Healthcare REIT stock hits 52-week high at 21.29 USD - Investing.com Nigeria
Sabra Healthcare REIT (NASDAQ:SBRA) Issues FY 2026 Earnings Guidance - MarketBeat
Sabra Health Care REIT raises 2026 guidance on portfolio moves - Investing.com
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):